Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes

Area of Science:

• Pharmacology
• Toxicology
• Enzymology

Background:

• Alpha-asarone is metabolized into epoxide-derived side-chain diols.
• Intermediately formed epoxides are mutagenic, form DNA adducts, and are linked to alpha-asarone's carcinogenicity in male mice.

Purpose of the Study:

• To investigate the role of eight human cytochrome P450 enzymes (CYP1A1, 1A2, 2A6, 2B6, 2C19, 2D6, 2E1, and 3A4) in alpha-asarone metabolism.
• To identify the specific enzymes responsible for side-chain epoxidation, hydroxylation, and O-demethylation.
• To assess the contribution of these enzymes to the formation of mutagenic metabolites.

Main Methods:

• Metabolism of alpha-asarone was studied using human liver microsomes and Supersomes™ containing specific cytochrome P450 enzymes.
• Formation rates of various metabolites (epoxides, diols, hydroxyasarone, O-demethylated products) were quantified.
• Relative activity factors (RAF) were applied to estimate enzyme contributions.

Main Results:

• CYP3A4 was the primary catalyst for alpha-asarone side-chain epoxidation, with contributions from CYP2B6 and CYP1A1.
• Side-chain hydroxylation was catalyzed by multiple CYPs (excluding CYP2A6).
• O-demethylation was mediated by CYP1A1, 2A6, 2B6, and 2C19.
• CYP3A4 was predominantly responsible for forming mutagenic epoxides at lower substrate concentrations.

Conclusions:

• Human hepatic CYPs, particularly CYP3A4, largely explain the side-chain hydroxylation and epoxidation of alpha-asarone.
• The capacity for metabolic activation of alpha-asarone is likely widespread in the general population.
• Further investigation may be needed to identify other enzymes involved in O-demethylation.